| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.6M | +3.6% |
| R&D Expense | $191.0M | +27.0% |
| SG&A Expense | $54.2M | +43.6% |
| Operating Income | -$235.6M | -31.7% |
| Income Tax | $0 | — |
| Net Income | -$212.2M | -22.0% |
| EPS (Basic) | -$2.91 | +12.9% |
| EPS (Diluted) | -$2.91 | +12.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $185.1M | -45.6% |
| Accounts Receivable | $1.1M | -53.3% |
| Current Assets | $611.3M | -1.9% |
| Total Assets | $628.6M | -1.6% |
| Current Liabilities | $80.7M | +55.4% |
| Total Liabilities | $127.8M | +110.4% |
| Stockholders' Equity | $500.8M | -13.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$119.1M | +12.6% |
| Capital Expenditures | $4.2M | +49.8% |
| Investing Cash Flow | -$130.1M | +31.5% |
| Financing Cash Flow | $93.9M | -72.9% |
| Free Cash Flow | -$123.3M | +11.4% |